To explore the mechanisms whereby deletion of myeloid TLR4 inhibits anti-GBM GN, we first examined the innate immune responses by immunohistochemical detection of neutrophils and macrophages infiltrating the diseased kidney. The gene discussed is TLR4; the disease is glioblastoma.